Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Sunrise LTK System not recommended for FDA approval

July 26, 1999

Alcon's new prostaglandin analogues for glaucoma

July 26, 1999

FDA Advisory Committee votes against recommending Allergan therapy for dry eye disease

July 26, 1999

FDA approves same-day, second-eye treatment with Sunrise LTK system

July 15, 1999

More on PEDF: protein also has ophthalmic indications

July 13, 1999

CAT gets U.K. approval to begin phase II trials of novel glaucoma treatment

July 12, 1999

Allergan ciclosporin NDA up for review this month by advisory committee

July 12, 1999

Midostaurin is a promising new agent for preventing vision loss

July 9, 1999

Chiron develops novel gene therapy for degenerative retinal disorders

July 6, 1999

Interim phase I/II data presented for Lu-Tex in age-related macular degeneration

July 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...